Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases
Research output: Contribution to journal › Journal article › peer-review
Dyspnea is considered as one of the most frequent and distressing symptoms in patients with advanced cancer, and systemic administration of morphine has been reported to have beneficial effect on this complaint.
Original language | English |
---|---|
Journal | Journal of Opioid Management |
Volume | 9 |
Issue number | 4 |
Pages (from-to) | 269-74 |
Number of pages | 6 |
ISSN | 1551-7489 |
DOIs | |
Publication status | Published - 2013 |
- Administration, Oral, Adult, Aged, Aged, 80 and over, Analgesics, Opioid, Chronic Pain, Denmark, Double-Blind Method, Dyspnea, Female, Heart Rate, Humans, Injections, Subcutaneous, Lung Neoplasms, Male, Middle Aged, Morphine, Respiratory Rate, Terminal Care, Time Factors, Treatment Outcome
Research areas
ID: 46132181